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Why is proteinuria an ominous biomarker of progressive kid-
ney disease? Progressive tubule injury and interstitial fibrosis
frequently accompany glomerulopathies associated with pro-
teinuria. Clinical experience indicates that higher levels of pro-
teinuria prior to, as well as after initiation of treatment pre-
dict more rapid decline in renal function and more pronounced
tubulointerstitial injury.
It has been proposed that filtration of potentially tubulotoxic
plasma proteins is responsible for the observed correlations be-
tween proteinuria and progression (i.e., proteinuria is a cause
and not only a consequence of progressive renal injury). Numer-
ous attempts have been made to identify the species of putative
tubulotoxic proteins in this progressive injury process, but much
uncertainty persists. These uncertainties stem from nonphysio-
logic exposure of apical cell surfaces to proteins in vitro, the ex-
tremely high concentrations of various proteins tested in vitro,
and the nonuniformity of end points measured. Furthermore,
there is often a lack of correlation between in vitro and in vivo
findings, and a lack of uniformity of results even for seemingly
similar in vitro experiments.
Less controversy is evident in the potential pathways
whereby injured tubules evoke a tubulointerstitial inflamma-
tory and fibrotic response, with many in vivo models serving to
incriminate excessive cytokine and chemokine production, in-
filtration of various inflammatory cells, and the balance between
apoptosis and cell proliferation.
Despite many years of concerted efforts, we believe it is still
unclear whether proteinuria is a cause (and if so, which species
of protein), or only a consequence of progressive renal injury.
Nevertheless, pending the resolution of these uncertainties by
more decisive and unambiguous experimentation, the strongly
predictive inverse relationship between level of proteinuria and
long-term renal survival currently justifies aggressive antipro-
teinuric treatment strategies, with a goal of reducing protein
excretion rate to the lowest level possible without the induction
of symptoms or undue risk.
Chronic renal injury, irrespective of cause, often relent-
lessly progresses to end-stage renal disease (ESRD). Pro-
teinuria is a common feature of chronic nephropathies,
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and in otherwise comparable groups of patients, those
with higher levels of proteinuria are at greater risk of
ESRD [1–3]. The recognition within the past two decades
that proteinuria is an independent predictor and a possi-
ble contributor to progression rather than a mere marker
of the severity of glomerular damage represents a ma-
jor change in our concepts of progressive kidney disease.
Furthermore, in studies of diabetic and nondiabetic kid-
ney disorders, early reduction in proteinuria is associ-
ated with slower progression of chronic kidney disease
(CKD) [4–9]. In the Ramipril Efficacy In Nephropathy
(REIN) study, the severity of initial proteinuria was as-
sociated with more rapid decline in glomerular filtration
rate (GFR) [10, 11]. A recent analysis of the REIN study
data showed that the level of residual proteinuria was also
a predictor of CKD progression, irrespective of blood
pressure control and treatment randomization [4]. Fur-
thermore, both the Modification of Diet in Renal Disease
(MDRD) study and a recent meta-analysis of 11 studies
involving 1860 patients with nondiabetic proteinuric re-
nal disease demonstrated that a reduction in urine protein
excretion was independently associated with a lower risk
of progression of CKD [12, 13]. Data from the Reduction
of End Points in NIDDM with Angiotensin II Antagonist
Losartan (RENAAL) study also showed that the base-
line urine albumin/creatinine ratio was the strongest in-
dependent predictor of reaching the combined end point
of doubling of baseline serum creatinine concentration or
ESRD among type 2 diabetic patients with nephropathy
[14], and again, the level of residual proteinuria during
therapy was as strong a marker of disease progression
as baseline proteinuria [9]. Finally, there is an increasing
body of evidence suggesting that proteinuria is also a car-
diovascular risk marker [15, 16]. Based on these results,
it is now widely accepted that reduction in proteinuria is
both renoprotective and cardioprotective and, thus, must
be considered as an independent therapeutic goal in the
management of patients with CKD.
The most intuitive and obvious explanation for the re-
lationship between proteinuria and progression of CKD
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is that the magnitude of proteinuria is merely a reflec-
tion of the severity of the underlying glomerular disease.
However, it has also been suggested that proteinuria di-
rectly contributes to renal injury and, in particular, to
tubule and interstitial pathology. Three general mecha-
nistic pathways have been suggested: one or more species
of filtered proteins (1) directly cause tubule damage and
apoptosis; (2) activate cellular response(s) that lead to
interstitial injury; (3) stimulate production of fibrogenic
molecules, such as transforming growth factor-b (TGF-b)
or endothelin-1 (ET-1).
PROTEIN FILTRATION AND UPTAKE
Protein filtration
Each day more than 60,000 g of protein normally
courses through the kidney, with less than 150 mg ap-
pearing in the final urine. The latter value refers to intact
proteins only, as measured by readily available laboratory
methods. If nonintact or partially degraded proteins are
also considered, the protein content of the final urine has
been estimated to be as high as 2 to 4 g/day [17, 18]. In this
review we will consider intact proteins only, as evaluated
by routine laboratory methods.
Under physiologic conditions low-molecular-weight
(LMW) proteins (molecular weight of less than 40 kD
and radius less than 30 A

) are freely filtered with re-
ported glomerular sieving coefficients (GSC) of 0.75 to
0.99 [18–20]. In contrast, filtration of high-molecular-
weight (HMW) proteins (molecular weight of more than
100 kD and radius greater than 55 A

) is almost completely
restricted [20]. As for filtration of the intermediate-
molecular-weight proteins, and albumin in particular,
early micropuncture studies reported albumin concentra-
tion in proximal tubule fluid to range from 0.3 to 73 mg/dL
[21–27]. More recently, Tojo and Endou found the con-
centration of albumin in the glomerular filtrate of rats
to be 2.3 mg/dL with a GSC of 0.00062 (with average
plasma albumin concentration of 3.7 g/dL) [18]. Low fil-
trate albumin concentration is consistent with the classic
concept of glomerular permselectivity, based on molec-
ular size, shape, and net charge [28]. However, other
recent studies have estimated the amount of filtered al-
bumin in rats to be much higher with a GSC of ∼7.5%,
which the authors extrapolated to a daily filtration of
more than 400 g of albumin in humans [29, 30]. These
studies employed cytotoxic chemicals to inhibit tubule
protein reabsorption, and may also have unintention-
ally led to loss of normal glomerular barrier integrity.
In support of this possibility, when tissue cooling was
used to inhibit tubule protein uptake, Ohlson et al ob-
tained results entirely consistent with the classic concept
of glomerular permselectivity, and found a GSC for albu-
min of 0.0019 (corresponding to glomerular filtrate albu-
min concentration of about 7.0 mg/dL) [31]. In addition,
a recent study measured the glomerular sieving coeffi-
cients of 12 different plasma proteins in human subjects
with severe impairment of proximal tubule protein ab-
sorption due to early Dent’s disease, Lowe’s syndrome, or
autosomal-dominant idiopathic Fanconi syndrome. The
glomerular sieving coefficients for intact albumin and im-
munoglobulin G (IgG) were found to be 0.000077 and
0.000042, respectively. The average concentration of al-
bumin in the glomerular filtrate was thus calculated to
be ∼0.35 mg/dL, which amounts to about 600 mg/day
[32]. When added to estimates of nonintact albumin of
∼1300 mg/day, we can infer that normal daily albumin
filtration in humans does not exceed ∼2000 mg/day (cor-
responding to ∼1.1 mg/dL) [17]. An even lesser filtered
quantity (more like 600 mg/day) emerges from the data in
Fanconi syndrome where disordered apical uptake would
be to preclude albumin uptake and degradation.
Albumin concentrations in glomerular filtrate in
proteinuric conditions have also been estimated. In
a micropuncture study of normal and puromycin
aminonucleoside-induced nephrotic rats, the average in-
tact albumin concentration of proximal tubule fluid in
normal rats was ∼2.5 mg/dL, whereas in nephrotic rats
it ranged from 15.7 mg/dL to 233 mg/dL [33]. In another
study in rats with immunologically mediated glomerular
disease the proximal tubule intact albumin concentration
averaged 7.4 mg/dL (up from 0.6 mg/dL in normal rats)
[22].
Glomerular proteinuria has been divided into selec-
tive and nonselective categories based on the selectivity
index (SI) [34]. Proteinuria with a ratio of IgG (a HMW
protein) to transferrin (or albumin) of less than 0.1 is
considered selective, whereas a ratio of more than 0.5 is
considered nonselective [35]. For a long time the selec-
tivity index of proteinuria was used to differentiate min-
imal change disease (with highly selective proteinuria)
from focal segmental glomerulosclerosis (with nonselec-
tive proteinuria). Two recent studies showed a direct re-
lationship between SI and the extent of tubulointerstitial
damage, as well as the likelihood of future progression of
renal disease [36, 37].
Protein uptake by proximal tubule cells
Oliver et al were among the first to appreciate that
“when proteins pass the glomerular filter they are in
part directly absorbed by the epithelial cells of the proxi-
mal convolution” [38]. Later, Straus, by using differential
centrifugation, morphologic techniques, and horseradish
peroxidase (as a probe protein), showed the segregation
of absorbed proteins in endosomes (phagosomes) follow-
ing their endocytic uptake by proximal tubule cells. He
further demonstrated that subsequent fusion of these en-
dosomes with lysosomes result in formation of phagolyso-
somes in which the absorbed proteins are ultimately
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digested by acid hydrolyses [39–45]. These concepts re-
ceived further support from Maunsbach, who showed
that 125I-labeled endogenous albumin injected into a sin-
gle rat proximal tubule lumen is taken up by the prox-
imal tubule cells, thereby providing further information
regarding pathways of uptake and lysosomal digestion
[46, 47].
The molecular mechanisms involved in the efficient
tubule absorption and processing of filtered proteins have
recently been elucidated. Megalin (gp 330) and cubu-
lin, two multiligand endocytic receptors, bind together
with high affinity and colocalize in many tissues, including
renal proximal tubule cells, where they are significantly
expressed in the brush border and the apical endocytic
apparatus [48]. Megalin, a 600 kD transmembrane pro-
tein and a member of the low density lipoprotein (LDL)
receptor family [49], is widely expressed in different cells,
including podocytes, thyroid and parathyroid cells, type II
pneumocytes, and endometrial cells, among others. Cubu-
lin (intestinal intrinsic factor cobalamin receptor) is a
460 kD membrane protein which is believed to rely, at
least in part, on megalin for internalization. Both megalin
and cubulin are involved in protein absorption by proxi-
mal tubule cells, capable of binding albumin, hemoglobin,
and immunoglobulin light chains [50]. In addition to their
common ligands each has its own specific group of ligands
(reviewed in [50, 51]).
A wealth of knowledge regarding specifications and
functional characteristics of these receptors has emerged
from studying megalin-knockout mice and dogs without
functional cubulin [52, 53]. A study of five adult megalin-
deficient mice showed increased proteinuria, particularly
LMW proteinuria, and a threefold increase in urinary
albumin/creatinine ratio (31 ± 12 vs. 11 ± 6 lg/mg in
wild-type). In addition, dogs with functional cubulin de-
ficiency showed a sevenfold increase in urinary albu-
min/creatinine ratio above wild-type [54].
POTENTIAL MECHANISMS OF
PROTEINURIA-INDUCED TUBULE CELL
INJURY
Misdirected filtration
This mechanism proposes that podocyte injury causes
adhesion of the glomerular tuft to Bowman’s capsule,
followed by accumulation of the “misdirected” filtrate
outside of Bowman’s space and into the periglomeru-
lar space, which is then separated from the interstitium
by a “layer of sheet-like fibroblast processes,” ultimately
resulting in glomerulosclerosis [55–60]. It further pro-
poses that most damaged tubules are served by damaged
glomeruli upstream. Similar adhesions were noted in up
to 90% of glomeruli of rats recovering from puromycin
aminonucleoside nephrosis (PAN) [61]. The extension
of this process to involve the proximal tubule and its
surrounding interstitium has been thought to result in
the separation of proximal tubule cells from their ad-
jacent basement membrane, with eventual tubule atro-
phy and interstitial fibrosis. This was first demonstrated
in models of focal segmental glomerulosclerosis (FSGS),
namely Fawn-hooded and Milan normotensive rats [59,
60]. Similar lesions were also noted in post-mortem
kidney tissue samples from patients with FSGS and dia-
betic nephropathy [60], and in a rat model of adriamycin-
induced nephropathy [62]. Further support for this
hypothesis has come from tracer studies in rat models of
FSGS demonstrating the presence of the tracers lissamine
green, and horse spleen ferritin within tuft adhesions to
Bowman’s space, periglomerular space, at the glomerulo-
tubular junction, and in peritubular subepithelial spaces,
providing further evidence for a role for misdirected fil-
tration of plasma proteins in renal injury [63].
Luminal obstruction by protein casts
Tissue samples from kidneys associated with heavy
proteinuria often demonstrate dilated tubules filled with
proteineous casts. In adriamycin-induced proteinuric
rats, cast formation was followed by tubule obstruction,
breakage of tubule basement membranes, extravasation
of tubule contents, and finally interstitial inflammation,
and fibrosis [64, 65]. Furthermore, tubule atrophy (both
proximal and distal to the obstruction) has been reported
following proximal tubule obstruction by wax placed by
micropuncture [66, 67]. However, the extent to which in-
traluminal casts contribute to tubule injury in proteinuric
nephropathies is unknown, mainly due to lack of ability to
prevent cast formation [62, 68]. Of note, the availability of
mice with germ-line deletion of Tamm-Horsfall protein
(uromodulin), a protein thought to be required for cast
formation, could prove helpful in resolving the role of
cast formation in tubulointerstitial injury in proteinuric
conditions [69, 70].
Tubule uptake of filtered proteins
Oliver et al suggested that protein droplets in proximal
tubule cells of kidneys with glomerular diseases might be
due to abnormal proximal tubule absorption and degra-
dation of filtered proteins (e.g., due to excessive filtra-
tion and an overwhelming of tubule mechanisms) [38].
A relationship between proteinuria and tubulointersti-
tial damage through excessive uptake by proximal tubule
cells was proposed in the studies evaluating renal biop-
sies of rats with proteinuria due to advanced age [71] or
adriamycin nephrosis [64]. These biopsies showed that
the excessive amounts of filtered plasma proteins accu-
mulated in the cytoplasm of proximal tubule cells, with
eventual focal extravasation of cell contents into the
neighboring interstitium, followed by an inflammatory
reaction, and tubulointerstitial fibrosis [64, 71, 72]. In
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addition, in studies of rats with overload proteinuria [73–
75], interstitial infiltration of macrophages and T lym-
phocytes was noted [75] and in two models of protein-
uric renal disease (5/6 nephrectomy and passive Hey-
mann nephritis), interstitial inflammation was localized
to the areas where proximal tubule cells contained IgG;
this was preceded by albumin and IgG accumulation in
these cells [72, 76]. Further support for this notion has
come from studies using intraperitoneal protein injec-
tion in the axolotl (Ambystoma mexicanum), a primi-
tive amphibian that has some open nephrons with ciliated
peritoneal funnels (nephrostomes) connecting peritoneal
cavity to proximal tubule lumen close to the glomerulus.
Following intraperitoneal injection of fetal bovine serum
(FBS), protein droplets were seen in tubule cells of these
open nephrons along with significant peritubular accu-
mulation of fibrous tissue. Other nephrons not open to
the peritoneum failed to show these changes [77].
Nagase analbuminemic rats (NAR) offer further in-
sight into the potential role of albumin versus other
plasma proteins in mediating tubulointerstitial injury.
Utilizing these rats, Osicka et al showed that the tubu-
lointerstitial injury following the induction of PAN and
antiglomerular basement membrane glomerulonephri-
tis was similar to that seen in control albumin-sufficient
Sprague-Dawley rats, thereby arguing for a pathogenetic
role for nonalbumin proteins [78].
Proteinuria is a common but variable feature
in patients with Imerslund-Grasbeck syndrome, an
autosomal-recessive inherited cubulin deficiency which
manifests as asymptomatic proteinuria from childhood
onwards. These patients also exhibit low serum vita-
min B12 levels, megaloblastic anemia, and neurologic
symptoms [79, 80]. Treatment with vitamin B12 corrects
the latter with no effect on proteinuria [80]. In a long-
term follow-up study of 14 affected patients (includ-
ing 10 from the original group reported in 1960), 10
had significant constant proteinuria (ranging from 300
to 1500 mg/day, average 750 mg/day), consisting mainly
of low- and intermediate-molecular-weight proteins, with
albumin making up about two thirds of the proteins.
These levels of albuminuria add further support to the
evidence cited above that under physiologic conditions
albumin filtration is less than 2 to 4 g/day. Of note, during
the follow-up of one to 39 years, the amount of protein-
uria did not increase, hypertension did not develop, and
all but two maintained normal kidney function (based on
serum creatinine and creatinine clearance values) [79].
Another recent study has confirmed these data, and again
showed normal kidney function despite consistency of
proteinuria (mainly albuminuria) in these patients [81].
The relatively brief duration of heavy albuminuria in
minimal change disease may be insufficient to evoke a
“cytokine” response and, thus, explain the relative ab-
sence of tubulointerstitial changes in the classic form of
steroid-sensitive, albeit, relapsing minimal change dis-
ease. It should also be mentioned that there are rare case
reports of long lasting nephrotic range albuminuria with-
out deterioration in kidney function or interstitial fibrosis
[82]. Based on these reports, it may be reasonable to infer
that nonabsorbed albumin, per se, is not tubulotoxic, and
that only when uptake by tubule cells is excessive and
chronic (due to chronic excessive filtration), does tubule
cell injury occur. Furthermore, since nonalbumin proteins
are present in the filtrate and urine of patients with cubu-
lin deficiency, their effects on the tubule, at least in the
normal quantities present, do not appear to be injurious.
WHAT IS THE POTENTIAL TUBULOTOXICITY
OF SPECIFIC PLASMA PROTEINS IN VITRO?
In vitro studies of the apical uptake of protein by prox-
imal tubule cells maintained in culture employed media
protein concentrations vastly in excess of those found in
proximal tubule fluid in vivo, and even far in excess of
proximal tubule fluid values found in animals whose urine
protein concentrations, are in the high nephrotic range.
In addition, it is noteworthy that proximal tubule cells are
routinely grown to confluence in media containing high
protein concentrations (5% to 10% fetal calf serum or fe-
tal bovine serum corresponding to ∼250–500 mg/dL, re-
spectively). Although there is usually a period of “growth
arrest” with no serum added to culture media for 24 to
48 hours prior to stimulation with protein(s) under inves-
tigation, it is still possible that such high concentrations
of serum proteins and/or growth arrest might have al-
tered cell phenotype and function and, thus, the outcome
of experiments. Indeed, it has recently been shown that
when more physiologic cell culture conditions are em-
ployed (i.e., protein added to basolateral but not apical
surfaces), cellular morphology and function differ drasti-
cally from patterns seen with protein added to both cell
surfaces [83]. Unfortunately, all the studies reported be-
low were performed under such nonphysiologic cell cul-
ture conditions (Fig. 1).
Albumin
Representative studies of albumin uptake by proximal
tubule cells in culture are summarized in Table 1. While
contamination with bacterial endotoxin [lipopolysaccha-
ride (LPS)] was not rigorously excluded in all studies, it
should be noted that in the majority of studies cited, the
level of LPS was less than 0.1 ng/mg of albumin. In one
study, high concentrations of albumin induced apoptosis
in a proximal tubule cell culture model, whereas simi-
lar concentrations of transferrin and IgG failed to do so;
the results were similar using either native or delipidated
bovine serum albumin (BSA) [84]. In two other studies,
pure yeast recombinant human serum albumin induced
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Albumin
Immunoglobulins
Ig light chain
Transferrin
Apotransferrin
Cytokines
etc., ???
Growth factros
Complement
components
Albumin-bound 
compounds
Lumen Proximal tubule cells Interstitium Vessel
Proteins
MCP-1
RANTES
IL-8
Fractalkine
Complement 
components
Chemotactic lipids
TGF-β
ET-1
Matrix
Epithelial-Mesenchymal
Transformation
L F
L
FF
L
MΦ
MΦ
Apoptosis
Fig. 1. Schematic summary of some of the
pathways and mediators that are believed
to be involved in proteinuria-induced tubu-
lointerstitial injury. RANTES, regulated upon
activation, normal T cell expressed and se-
creted; IL-8, interleukin-8; MCP-1, monocyte
chemoattractant factor-1; ET-1, endothelin-1;
TGF-b , transforming growth factor-b ; M,
macrophage; L, lymphocyte; F, fibroblast; E,
endothelial cell.
cell proliferation through phosphatidylinositide 3-kinase
(PI 3-kinase)- and extracellular-signal-regulated kinase
(ERK, a member of mitogen-activated protein kinase)-
dependent pathways; of note, the response to albumin
was several-fold less than the response to 10% fetal calf
serum (FCS), whereas there was no response to oval-
bumin. Although the maximum response was noted at
albumin concentration of 100 mg/dL, significant positive
results were noted with albumin concentrations as low
as 10 mg/dL [85, 86]. Another study using primary cul-
ture of human proximal tubule cells showed a modest
increase in thymidine uptake (a marker for cell prolif-
eration) when exposed to 100 mg/dL normal unfraction-
ated human serum. Further studies showed similar re-
sults following exposure to a similar high concentration
of a plasma fraction of molecular weight of 40 to 100 kD.
This is the fraction that contains albumin and transferrin;
TGF-b was not detected in this fraction. However, use
of pure human albumin (100 mg/dL) and pure partially
iron saturated transferrin (5 mg/dL, similar concentra-
tion to unfractionated serum) failed to reveal evidence of
proliferation. In addition, the fraction containing LMW
proteins, including most of the cytokines and growth fac-
tors, also failed to have an effect on proliferation [87].
A similar study failed to show an increase in basolateral
fibronectin (an extracellular matrix protein) production
by proximal tubule cells exposed to albumin, whereas ex-
posure to serum did provoke an increase. Addition of the
serum was associated with increased lactate dehydroge-
nase (LDH) level, suggestive of cytotoxicity [88].
A group of studies using proximal tubule cells in cul-
ture showed that high concentrations of albumin induced
the expression of chemokines RANTES (regulated
upon activation, normal T cell expressed and se-
creted), MCP-1 (monocyte chemoattractant protein-1),
and fractalkine via an NF-jB (nuclear factor kappa B)-
dependent pathway subsequent to generation of intra-
cellular reactive oxygen species (ROS) [89–92]. In ad-
dition, this up-regulation was associated with increased
basolateral release of chemokines [90]. In one of these
studies the renal level of fractalkine mRNA was in-
creased 2.3-fold in mice with BSA-overload proteinuria
[89]. In a recent study, albumin up-regulated interleukin-
8 (IL-8) production by human proximal tubule cells in a
time- and concentration-dependent (125 to 2000 mg/dL)
manner. This up-regulation was again subsequent to in-
tracellular ROS generation and NF-jB activation. Of
note, boiled human serum albumin (HSA), trypsin-
digested HSA, and IgG, at the concentration equal to
intact HSA (1000 mg/dL), failed to elicit similar results,
whereas transferrin induced a positive, albeit lesser, ef-
fect than albumin. Interestingly, exposure of cells to sim-
ilar concentrations of albumin at their basolateral side
also induced IL-8 production, although to a significantly
lesser extent [93].
Lipids and fatty acids bound to albumin
It is well known that nephrotic-range proteinuria is as-
sociated with hyperlipidemia, and it has been shown that
fatty acid content of albumin dramatically increases un-
der nephrotic conditions [94], thereby exposing proximal
tubule cells to large amounts of fatty acid-loaded albu-
min. The role of fatty acids in tubulointerstitial injury
was first proposed in a rat model of overload proteinuria
in which the urine of the rats contained a chemotactic
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factor for macrophages that proved to be a novel nonpo-
lar lipid derived from the metabolism of these fatty acids.
In addition, culture media from proximal tubule segments
exposed to high concentrations of lipid-repleted BSA
also showed chemotactic activity, whereas equivalent ex-
periments with delipidated BSA produced little such ac-
tivity [95]. Similarly, in studies of an in vivo model of
overload proteinuria animals injected with free fatty acid
(FFA)-repleted BSA had higher levels of macrophage
infiltration and tubulointerstitial damage in comparison
to the groups injected with FFA-depleted BSA [96, 97].
The proximal tubule uptake of albumin, however, was
similar in FFA-repleted and FFA-depleted groups [96].
In an effort to differentiate the effect of different fatty
acids, Arici et al studied the effects of four different fatty
acids bound to albumin (palmetate, stearate, oleate, and
linoleate) on cell toxicity and fibronectin production in
human proximal tubule cells in culture. Oleic acid and
linoleic acid were found to be the most profibrogenic
and tubulotoxic fatty acids [98]. Interestingly, it has been
shown that the urine albumin load of fatty acids in hu-
man minimal change disease is significantly lower in com-
parison to other nephrotic conditions; the difference was
more pronounced for linoleic acid, followed by oleic acid
[99].
Transferrin and iron
Initial studies held iron responsible for the tubulointer-
stitial scarring seen in proteinuric conditions because they
showed a correlation between proximal tubule cell lyso-
somal iron concentration and tubulointerstitial damage
[100, 101]. It has been suggested that upon entering the
relatively acidic milieu of proximal tubule fluid, iron can
be dissociated from transferrin, resulting in ROS produc-
tion and subsequent damage particularly to brush border
membrane [100, 102]. In addition, upon entering proxi-
mal tubule cells (along with transferrin), reactive iron can
be released from transferrin inside the lysosomes, leave
the lysosomes, and enter the cytoplasm as free reactive
iron, where it can stimulate ROS production and subse-
quent cellular injury [101]. However, later experiments
by the same investigators failed to show any benefit of
iron deficiency in these conditions [103]. Further studies
(Table 2) showed that both apotransferrin (iron-deficient
transferrin) and holotransferrin (in extremely high con-
centrations from 100 to 800 mg/dL) could induce MCP-1
production by proximal tubule cells [104]. In human prox-
imal tubule cells in culture both transferrin and apotrans-
ferrin (250 to 4000 mg/dL, maximum response reached
at 1000 mg/dL) induced complement C3 production by
the cultured cells, whereas similar concentrations of al-
bumin failed to provoke a positive response. However,
this conclusion regarding albumin’s effect is questionable
because C3 production in cells incubated with serum-free
medium was significantly increased after 48 hours, reach-
ing values close to those induced by 1000 mg/dL of trans-
ferrin. Thus, it is possible that a positive response could
be noted if cells were exposed to albumin for longer pe-
riods [105]. In another in vitro study of proximal tubule
cells, high concentrations of transferrin induced MCP-1,
IL-8, and macrophage migration inhibitory factor (MIF)
expression [106].
Immunoglobulins and light chains
Several studies have investigated the effects of IgG and
light chains on proximal tubule cells (Table 3) (to the best
of our knowledge, studies involving IgM, IgE, and IgA
have not been reported). In porcine proximal tubule cells
(LLC-PK1), IgG (100 to 3000 mg/dL) induced RANTES
production and its mainly basolateral release by these
cells [90]. In a similar study in human proximal tubule
cells (HK-2), IgG incubation (100 to 3000 mg/dL, 5 to
60 min) induced ROS, which in turn activated NF-jB
and its downstream inflammatory signals [91].
Light chains are relatively small proteins with a molec-
ular weight of approximately 30 kD and, thus, freely fil-
tered by normal glomeruli [107]. Certain conditions, such
as multiple myeloma and other myeloproliferative disor-
ders, can result in overproduction of these light chains
with their subsequent appearance in urine (Bence-Jones
proteins). In addition to cast nephropathy, which is the
most common renal presentation, these light chains can
cause light chain deposition disease (LCDD), Fanconi
syndrome, and other tubulopathies. Upon entering the
lumen of the proximal tubule, light chains are taken up by
proximal tubule cells via a receptor-mediated pathway in-
volving megalin and cubulin, where they may prove toxic
to these cells [108–110]. A recent study using immortal-
ized human proximal tubule cells in culture and eight dif-
ferent light chains showed suppressed proliferation and
increased apoptosis, and even necrosis, in exposed cells.
Cells were exposed to a range of 0 to 800 lmol/L (∼0–
2400 mg/dL) of light chains for up to 48 hours, and were
grown in a medium containing 0.5% (∼25 mg/dL) fetal
bovine serum (FBS). There was a difference in the effect
among light chains, with some being more toxic than oth-
ers. In addition, a concentration-dependent response, ir-
respective of the light chain type, was noted, implying the
importance of protein load [107]. Another recent study
evaluated the effect of light chains versus HSA on pro-
duction of different proinflammatory cytokines by human
proximal tubule cells. The results showed that light chains
(150 to 300 mg/dL) could induce the release of proin-
flammatory cytokines, including interleukin-6 (IL-6),
IL-8, and MCP-1 in a NF-jB–dependent manner,
whereas human serum albumin (up to 3000 mg/dL) failed
to do so. NF-jB inhibitors and maneuvers interfering with
light chain endocytosis abolished these responses [111].
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Filtered cytokines and growth factors
In addition to albumin, transferrin, and immunoglob-
ulin light chains, high-molecular-weight plasma proteins
can enter the urine under nonselective proteinuric con-
ditions. In serum, insulin growth factor-I (IGF-I) exists
in 50 or 150 kD forms, preventing it from normally ap-
pearing in glomerular ultrafiltrate [112]. However, it has
been detected in the urine of nephrotic diabetic rats
[112, 113]. In these rats, IGF-I is biologically active and
capable of increasing secretion of types I and IV col-
lagen by proximal tubule cells in culture; this effect is
partially ameliorated by IGF-I receptor antibody [113].
TGF-b and hepatocyte growth factor (HGF) are other
proteins incapable of entering urine under physiologic
conditions due to their high molecular weight. Receptors
for both of these ligands are present on the apical surface
of renal epithelial cells [114]. The majority of TGF-b in
the plasma is biologically inactive due to its association
with different proteins, namely latency associated pep-
tide (LAP, 100 kD), tertiary protein complex of LAP, and
latent TGF-b binding protein (LAP-LTBP, 220 kD), or
a2 microglobulin (∼900 kD). If filtered in disease, trans-
formation of the inactive to active form may occur in
the tubule by increased urea concentration, urokinase,
or thrombospondin-1 [114–116]. In a rat model of dia-
betic nephropathy, mature HGF and active and latent
TGF-b were detected in early proximal tubule fluid. In
the same study, incubation of mouse proximal tubule cells
in culture with fluid collected from the proximal tubule of
diabetic rats induced up to threefold greater expression
of MCP-1 and RANTES (both at mRNA and protein
levels). Incubation with recombinant human HGF and
TGF-b produced similar results, whereas high glucose
(450 mg/dL), BSA (10 mg/dL), rat albumin (10 mg/dL),
and IGF-1 (10 nmol/L) failed to evoke positive responses
[117]. Furthermore, in contrast to these findings, a large
group of studies have pointed toward an antifibrotic role
for HGF [118–120].
Complement
Several lines of evidence point to a role for comple-
ment in initiating tubulointerstitial damage in protein-
uric states. In two studies in proteinuric rats, complement
inhibitors were able to reduce tubulointerstitial dam-
age and preserve renal function [121, 122]. In addition,
piebald viral glaxo (PVG) rats unable to produce C5-9
membrane attack complex (MAC) due to a genetic C6
deficiency were protected against tubulointerstitial dam-
age associated with proteinuria [123, 124]. Furthermore,
blocking the expression of Crry, a complement regulatory
protein in rats, was associated with increased tubuloint-
erstitial damage [125, 126]. In proximal tubule cells in
culture, MAC induced expression of proinflammatory cy-
tokines IL-6 and tumor necrosis factor-a (TNF-a) [127].
Complement components, including the C5-9 complex,
were detected in proteinuric urine, although the large
size of this complex argues against entry via filtration. Al-
though in certain conditions, namely human membranous
glomerulopathy and rat Heymann nephritis, the source of
MAC in the urine can be glomerular shedding, it has also
been detected in the urine of proteinuric patients with-
out a source in their glomeruli [126, 128]. This implies
the possibility that MAC can be assembled in the lumen
following glomerular filtration of individual complement
components. In fact, it has been shown that apical mem-
branes of proximal tubule cells are capable of activating
the complement system directly and through the alterna-
tive pathway, further supporting this possibility [129].
HOW MIGHT FILTERED PROTEINS INITIATE
TUBULOINTERSTITIAL FIBROSIS?
Effects on cytokine and chemokine production
by proximal tubule cells
The infiltration of inflammatory cells following renal
injury is dependent on chemotactic factors and adhe-
sion molecules. The most potent chemoattractants are
chemokines, small proteins with molecular weights of ap-
proximately 10 kD that can be produced by a variety
of cells, including renal epithelial cells and activated im-
mune cells. Chemokines are further categorized such that
CC chemokines are mainly involved in chemoattraction
of monocytes and lymphocytes, whereas chemokines of
C-X-C family usually attract neutrophils. A host of in
vitro and in vivo studies has shown induction of MCP-1
and RANTES (members of CC subfamily) by proximal
tubule cells upon exposure to extremely high concentra-
tions of proteins (Fig. 1) [90, 92, 130]. Of note, the resul-
tant chemokine secretion was polarized mainly toward
the basolateral aspect of the cell. In vitro studies have
shown similar results for fractalkine, a chemokine from
the C-X3-C subfamily with both chemokine and adhesion
molecule properties [89], and IL-8, a chemokine from the
C-X-C family that is chemotactic for both neutrophils and
lymphocytes [93]. In addition, these studies have shown
that generation of ROS and activation of NF-jB are in-
volved in the chemokine secretory process [89–93].
TGF-b is believed to be one of the mediators through
which proximal tubule cells are capable of directly stim-
ulating adjacent interstitial fibroblasts, in addition to any
indirect stimulatory effect via infiltrating inflammatory
cells (e.g., macrophages). An in vitro study of proximal
tubule cells in culture has shown an increased expres-
sion of TGF-b in response to high concentrations of
albumin (10–100 mg/dL) [131]. In a study of the rat
remnant kidney model, up-regulation of TGF-b mRNA
in proximal tubule cells followed the uptake of fil-
tered proteins (IgG) by these cells [132]. In addition, a
study of kidney biopsy samples from patients with heavy
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proteinuria (8.4 ± 3.0 g/day) found proximal tubule cells
as the main site of TGF-b synthesis and expression [133].
Endothelin-1 (ET-1) is a peptide with chemotactic
(for macrophages) and pro-proliferative characteristics
in addition to its ability to induce vasoconstriction [134–
136]. In an in vitro study, high concentrations (100 to
1000 mg/dL) of various proteins (albumin, transferrin,
and IgG) induced ET-1 expression by rabbit proximal
tubule cells [136]. Further evidence supporting the role
of ET-1 in the progression of renal damage has come
from transgenic mice over-expressing ET-1 in their kid-
neys. These mice develop renal lesions despite normal
systemic blood pressure. In addition, results from studies
using an ET receptor antagonist support a role for ET-1
in the progression of renal scarring [137].
Effects on apoptosis
One of the pathways to tubule atrophy is apoptosis, or
more accurately, an increased rate of apoptosis of proxi-
mal tubule cells relative to their rate of proliferation. A
cell culture study using very high concentrations of al-
bumin (up to 2000 mg/dL) has shown an increased level
of apoptosis (in comparison with appropriate controls)
due, at least in part, to a Fas-FADD-caspase 8 pathway.
The authors hypothesized that apoptosis may be a means
by which sublethally injured cells can be removed by ei-
ther neighboring cells (in a Fas-dependent pathway) or by
inflammatory cells infiltrating the adjacent interstitium,
clearing the path for tubule regeneration [84]. Indeed, in
proximal tubule cells in culture, activated macrophages
induced apoptosis through release of an as yet uniden-
tified soluble factor, and in the absence of direct cell-
to-cell contact [138]. In addition, studies in an in vivo
model of overload proteinuria (using fatty acid-carrying
BSA) showed both increased tubule cell proliferation
and apoptosis, with the latter being the dominant fea-
ture [97, 139]. In contrast, other studies have shown that
cell proliferation predominates. Studies on human kid-
ney biopsies from patients with proteinuric glomerulopa-
thy (e.g., membranous nephropathy and minimal change
nephropathy) have shown increased proliferation and hy-
perplasia of proximal tubule cells [87, 140]. Studies of
proximal tubule cells in vitro have shown similar results
[85–87, 141]. In an effort to reconcile the conflicting re-
sults of different studies, Erkan et al have proposed that if
exposure to high protein concentrations is of short dura-
tion, proliferation will dominate and tubules will regener-
ate, whereas in chronic severe proteinuria apoptosis will
prevail, resulting in tubular atrophy [84]. Further studies
will be required to clarify this issue.
Role of inflammatory cells
Interstitial infiltration of mononuclear inflammatory
cells (mainly macrophages and lymphocytes) can be seen
in a variety of immune- and nonimmune-mediated kid-
ney disorders, including remnant kidney and protein-
overload proteinuric models (reviewed in [142]), where
cell infiltration is thought to play a significant role in
tubulointerstitial damage and fibrosis. The mechanisms
involved in the recruitment of mononuclear inflamma-
tory cells and their role in induction of fibrosis is com-
plex and beyond the scope of this paper (reviewed in
[142, 143]). Briefly, it is thought that renal tubule cells,
upon exposure to high protein concentrations, produce a
host of chemokines, vasoactive mediators, and adhesion
molecules (vide supra), resulting in interstitial infiltration
and activation of mononuclear inflammatory cells, which,
if they persist, may then contribute to interstitial fibrosis.
It should be remembered that infiltrating cells are not al-
ways harmful, and may in fact be beneficial by helping to
repair the tissues they infiltrate [68]. Support for a patho-
genetic role of mononuclear inflammatory cell infiltration
has come from studies in which a reduction in infiltration
has been associated with reduced renal injury and pre-
served renal structure and function [144, 145]. In a model
of unilateral ureteral obstruction, blocking of chemokine
receptor CCR-1 by an antagonist was associated with re-
duced infiltration of lymphocytes and macrophages and
less interstitial fibrosis [146]. Recently, studies have ex-
amined the potential benefit of mycophenolate mofetil
(MMF), a reversible inhibitor of de novo purine synthe-
sis essential for lymphocyte proliferation. In the remnant
kidney model, MMF reduced mononuclear cell infil-
tration and interstitial fibrosis without affecting the
magnitude of proteinuria, glomerular hypertension, or
hypertrophy [147]. In a similar study in the remnant kid-
ney model, MMF reduced the infiltration of mononuclear
inflammatory cells and abolished the progressive renal
damage, again with no effect on systemic hypertension
or glomerular hypertrophy [148]. However, it has been
shown that MMF has favorable effects on single nephron
GFR (SNGFR), glomerular injury, and magnitude of pro-
teinuria, and therefore, the extent to which its beneficial
effects can be attributed solely to its role in attenuating
interstitial infiltration remains unclear [149].
CONCLUSION
Progressive tubule injury and interstitial fibrosis fre-
quently accompany glomerulopathies associated with
proteinuria. Clinical experience indicates that higher lev-
els of proteinuria prior to, as well as after initiation of
treatment predict more rapid decline in renal function
and more pronounced tubulointerstitial injury. In addi-
tion, the composition of the abnormal protein excretion
(e.g., IgG content) has a powerful predictive influence
on progression, perhaps reflecting the greater nonselec-
tive glomerular wall damage. It has been proposed that
filtration of potentially tubulotoxic plasma proteins is
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responsible for the observed correlations between pro-
teinuria and progression (i.e., proteinuria is a cause and
not only a consequence of progressive renal injury). Nu-
merous attempts have been made to identify the species
of putative tubulotoxic proteins in this progressive injury
process, but much uncertainty persists. These uncertain-
ties stem from nonphysiologic exposure of apical cell sur-
faces to proteins in vitro, the extremely high concentra-
tions of various proteins tested in vitro, and the nonuni-
formity of end points measured. Furthermore, there is
often a lack of correlation between in vitro and in vivo
findings and a lack of uniformity of results, even for seem-
ingly similar in vitro experiments. Although many long-
term human follow-up studies support little or no tubu-
lotoxic potential for albumin, several in vivo and in vitro
studies have been taken to suggest otherwise. For other
plasma protein species, similar variability in injury po-
tential exists. Less controversy is evident in the potential
pathways whereby injured tubules evoke a tubulointer-
stitial inflammatory and fibrotic response, with many in
vivo models serving to incriminate excessive cytokine and
chemokine production, infiltration of various inflamma-
tory cells, and the balance between apoptosis and cell
proliferation.
Despite many years of concerted efforts, we believe
it is still unclear whether proteinuria is a cause (and if
so, which species of protein) or only a consequence of
progressive renal injury. It remains possible that pro-
gression (i.e., the loss of GFR) in chronic proteinuric
glomerulopathies is the direct result of pathophysiologic
processes arising within the glomeruli themselves (e.g.,
capillary hypertension, loss of capillary surface area,
mesangial expansion, etc.). In this scenario, the magni-
tude and compositional characteristics of the proteinuria
are merely manifestations of the extent of the underly-
ing glomerular wall injury. Alternatively, events occurring
downstream from the glomerular capillary circulation,
arising from altered permselectivity, may indeed be re-
sponsible for progression. These alternative views of the
pathogenesis of progression are not mutually exclusive;
however, experiments reported thus far do not reliably
distinguish between them. It should also be noted that
in vivo and in vitro experiments yielding positive find-
ings are far more likely to be accepted for publication
than those yielding negative results. Despite the publica-
tion bias, our review of available literature justifies our
cautious interpretations and conclusions. Nevertheless,
pending the resolution of these uncertainties by more
decisive and unambiguous experimentation, the strongly
predictive inverse relationship between level of protein-
uria and long-term renal survival currently justifies ag-
gressive antiproteinuric treatment strategies, with a goal
of reducing protein excretion rate to the lowest level
possible without the induction of symptoms or undue
risk.
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